Skip to main content

CITADEL ADVISORS LLC

Position in ANVS — Annovis Bio, Inc.

CIK 1423053 MIAMI, FL

Position in ANVS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$453,247
+$453,247 QoQ
Shares Held
243,682
Ownership
0.572%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 61 holders
Holding Since
Sep 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANVS Over Time

Shares Held

Position Value (USD)

Derivatives in ANVS

reported options exposure · as of Jun 30, 2026
CallValue
$213,528
CallShares
114,800
PutValue
$275,280
PutShares
148,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,182 across 436 Biotechnology names. ANVS ranks #273 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ANVS

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $453,247 243,682
2026-06-30 $275,280 148,000
2026-06-30 $213,528 114,800
2026-03-31 $130,009 58,300
2026-03-31 $103,918 46,600
2025-12-31 $562,250 162,500
2025-12-31 $150,164 43,400
2025-09-30 $79,902 38,600
2025-09-30 $226,044 109,200
2025-09-30 $360,894 174,345
2025-06-30 $73,563 33,900
2025-06-30 $63,637 29,326
2025-06-30 $71,610 33,000
2025-03-31 $115,050 76,700
2025-03-31 $72,900 48,600
2024-12-31 $1,082,491 215,207
2024-12-31 $1,536,665 305,500
2024-12-31 $75,450 15,000
2024-09-30 $2,132,676 264,600
2024-09-30 $143,468 17,800
2024-09-30 $827,697 102,692
2024-06-30 $794,304 137,900
2024-06-30 $878,400 152,500
2024-03-31 $11 1
2024-03-31 $1,050,770 88,300
2024-03-31 $1,393,490 117,100
2023-12-31 $43,010 2,300
2023-12-31 $1,032,240 55,200
2021-12-31 $1,039,804 59,147
2021-09-30 $1,181,798 37,222